| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029495 |
| Receipt No. | R000033695 |
| Scientific Title | A study 2 for evaluation of inter-fractional changes in internal organs and its dose distributions for carbon ion radiotherapy |
| Date of disclosure of the study information | 2017/10/16 |
| Last modified on | 2019/12/19 (Ver. 2) |
| Basic information | ||
| Public title | A study 2 for evaluation of inter-fractional changes in internal organs and its dose distributions for carbon ion radiotherapy | |
| Acronym | Evaluation 2 of influence for inter-fractional changes for carbon ion radiotherapy | |
| Scientific Title | A study 2 for evaluation of inter-fractional changes in internal organs and its dose distributions for carbon ion radiotherapy | |
| Scientific Title:Acronym | Evaluation 2 of influence for inter-fractional changes for carbon ion radiotherapy | |
| Region |
|
|
| Condition | ||
| Condition | Prostate, pancreatic, or uterine cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate interfractional anatomical changes and dose distributions using CT images acquired in every treatment days. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To evaluate tumor movement using CT images acquired on the treatment days and the treatment planning CT images.
To recalculate the CTV coverage (V95%) on the current CT images and compare with the CTV coverage on the treatment planning. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Twelve to sixteen times at maximum (three to four times at least) of CT acquisitions and one time of 4 dimensional CT acquisition
|
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patient has a prostate, pancreatic, or uterine cancer, and he/she will receive carbon ion radiotherapy.
The treatment fractions is twelve to sixteen. ECOG Perfomance Status (PS)=0-2. Over 20 years. It is possible to get his/her agreement of this study by text. |
|||
| Key exclusion criteria | Not emergency irradiation case.
Inappropriate case determined by doctor. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, Gunma University
|
||||||
| Division name | Radiation Oncology | ||||||
| Zip code | |||||||
| Address | 3-39-22, Showa-Machi, Maebashi, Gunma | ||||||
| TEL | 027-220-8380 | ||||||
| tnakano@gunma-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gunma University | ||||||
| Division name | Heavy Ion Medical Center | ||||||
| Zip code | |||||||
| Address | 3-39-22, Showa-Machi, Maebashi, Gunma | ||||||
| TEL | 027-220-8378 | ||||||
| Homepage URL | |||||||
| tohno@gunma-u.ac.jp | |||||||
| Sponsor | |
| Institute | Gunma University Heavy Ion Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Gunma University Heavy Ion Medical Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033695 |